Lorraine Chiroiu was named CEO of AusBiotech in 2018, officially taking the reigns of the organisation on 3 July 2018. Lorraine succeeded Glenn Cross, who served as CEO for 2 years and COO for 11 years. Glenn succeeded Dr Anna Lavelle, who served as CEO for 11 years and was awarded a Life Membership to AusBiotech.
